Chairman, Department of Neurology, NorthShore University HealthSystem; Medical Director, NorthShore Neurological Institute
Neurology
Dr. Demetrius M. Maraganore, MD
|
|
Give Review
Demetrius Maraganore is an expert in the field of Neurology. He went to medical school at Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19/29 in Research/PrimaryCare. He has 4 awards "Chicago Magazine: Top Doctors", "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Dr. Demetrius M. Maraganore is a published doctor. He has 100 papers published. The most current publication "Quality improvement and practice-based research in neurology using the electronic medical record." He is registered with Medicare and accepts Medicare payments.
Publications
- Quality improvement and practice-based research in neurology using the electronic medical record.
- Role for the microtubule-associated protein tau variant p.A152T in risk of alpha-synucleinopathies.
- Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.
- Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement.
- Nicholas A. Vick, MD (1939-2014).
- Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease.
- Lack of Replication of the GRIN2A-by-Coffee Interaction in Parkinson Disease.
- Alpha-synuclein repeat variants and survival in Parkinson's disease.
- Rationale for therapeutic silencing of alpha-synuclein in Parkinson's disease.
- Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?
- Population-specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO-PD) consortium.
- The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
- Genetic susceptibility loci, environmental exposures, and Parkinson's disease: A case-control study of gene-environment interactions.
- A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.
- Genomic determinants of motor and cognitive outcomes in Parkinson's disease.
- Large-scale replication and heterogeneity in Parkinson disease genetic loci.
- Mutations in CIZ1 cause adult onset primary cervical dystonia.
- Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.
- Association of LRRK2 exonic variants with susceptibility to Parkinson''s disease: a case-control study.
- Role of sepiapterin reductase gene at the PARK3 locus in Parkinson''s disease.
- Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease.
- Perimenopausal risk factors and future health.
- Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
- Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies?
- Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
- Variants in estrogen-related genes and risk of Parkinson's disease.
- A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson''s disease.
- Common variants in PARK loci and related genes and Parkinson's disease.
- Anxious personality predicts an increased risk of Parkinson's disease.
- Novelty seeking and introversion do not predict the long-term risk of Parkinson disease.
- Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson''s disease: large-scale collaborative study.
- Medical records documentation of constipation preceding Parkinson disease: A case-control study.
- Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study.
- Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.
- Bell's palsy preceding Parkinson's disease: a case-control study.
- Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study.
- Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.
- Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics.
- In vivo silencing of alpha-synuclein using naked siRNA.
- Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging.
- Premenopausal oophorectomy and the risk for dementia.
- Association study of semaphorin 5A with risk of Parkinson's disease in a Chinese Han population.
- Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy.
- Coffee, caffeine-related genes, and Parkinson's disease: a case-control study.
- Genomic investigation of alpha-synuclein multiplication and parkinsonism.
- Alpha-synuclein, pesticides, and Parkinson disease: a case-control study.
- The long-term effects of oophorectomy on cognitive and motor aging are age dependent.
- Increased risk of parkinsonism in women who underwent oophorectomy before menopause.
- Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway.
- Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease.
- Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease.
- Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.
- Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease.
- Investigation of the PARK10 gene in Parkinson disease.
- Calf venous compliance in multiple system atrophy.
- Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study.
- A genomic pathway approach to a complex disease: axon guidance and Parkinson disease.
- Number of children and risk of Parkinson's disease.
- Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease.
- The emergence of networks in human genome epidemiology: challenges and opportunities.
- Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies.
- Direct medical costs associated with Parkinson's disease: a population-based study.
- Chemical exposures and Parkinson's disease: a population-based case-control study.
- Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia.
- Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies.
- Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
- Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study.
- Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study.
- The Mayo Clinic cohort study of personality and aging: design and sampling, reliability and validity of instruments, and baseline description.
- Comorbid conditions associated with Parkinson's disease: a population-based study.
- Structural basis for conformational plasticity of the Parkinson's disease-associated ubiquitin hydrolase UCH-L1.
- Reliability of self-reported ancestry among siblings: implications for genetic association studies.
- A road map for efficient and reliable human genome epidemiology.
- Education and occupations preceding Parkinson disease: a population-based case-control study.
- High-resolution whole-genome association study of Parkinson disease.
- LRRK2 mutations in Parkinson disease.
- A network of investigator networks in human genome epidemiology.
- Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study.
- Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study.
- UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study.
- The Mayo Clinic family study of Parkinson's disease: study design, instruments, and sample characteristics.
- Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease.
- Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.
- Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
- Blood is thicker than water: the strengths of family-based case-control studies.
- Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
- Familial aggregation of Parkinson's disease: The Mayo Clinic family study.
- A limited role for DJ1 in Parkinson disease susceptibility.
- Increased risk of head tremor in women with essential tremor: longitudinal data from the Rochester Epidemiology Project.
- UCHL1 is a Parkinson's disease susceptibility gene.
- Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.
- Parkin variants in North American Parkinson's disease: cases and controls.
- Case-control study of the alpha-synuclein interacting protein gene and Parkinson's disease.
- alpha-Synuclein locus triplication causes Parkinson's disease.
- Validity of family history data on PD: evidence for a family information bias.
- Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China.
- Complex interactions in Parkinson's disease: a two-phased approach.
- Head trauma preceding PD: a case-control study.
- Survival study of Parkinson disease in Olmsted County, Minnesota.
Schools
Northwestern University Feinberg School Of Medicine
Mayo Clinic Graduate School Of Medicine
Mayo School of Graduate Medical Education
National Hospital For Neurology and Neurosurgery
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Chicago Magazine: Top Doctors
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Mayo School of Graduate Medical Education -
Northwestern University Feinberg School of Medicine
Hospital
-
NorthShore University Health System -
NorthShore Skokie Hospital
Drug Facts
| NPI NUMBER | 1427035278 | |
| NPPES Provider LastName | MARAGANORE | |
| NPPES Provider FirstName | DEMETRIUS | |
| NPPES Provider ZIPCode | 600261301 | |
| NPPES Provider State | IL | |
| Specialty Description | Neurology | |
| Total Claim Count | 698.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427035278 |
| Last Name Of The Provider | MARAGANORE |
| First Name Of The Provider | DEMETRIUS |
| View All |
Similar Doctors
|
Dr. Trupti B. Gokani, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Charulatha Nagar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laura G. Goldstein, MD |
|
Dr. William C. Davison, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Aikaterini Markopoulou, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mari Viola Saltzman, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Barry H. Weber, MD |
|
Dr. Lawrence D. Robbins, MD
This Doctor is OpenDoctor Recommended.
|